Targeting stroke to develop stem cell therapies is a hot direction at present. Much data have shown that stem cell
therapy is a potentially effective pathway for subacute and chronic stroke. Stem treats stroke through
two main pathways: cell differentiation and secretion of paracrine factors, Ace Therapeutics
provides comprehensive preclinical research services, from screening for appropriate stem cell types to safety
evaluation, to promote the development of your stem
for stroke.
The first step in developing stem cell therapies for stroke is to screen for the appropriate stem cell type, which
can notably affect the outcome of stem . Ace Therapeutics has
an extensive cell bank covering the types
of stem cells that can be used to develop stem cell therapies, including but not limited to adult tissue-derived
stem cells (neural stem cell, mesenchymal stem cells), adipose tissue-derived MSCs, breastmilk-derived stem cells,
and menstrual blood stem cells. Based on our stem cell bank, our expert scientists will select the most suitable
type of stem cells for you based on both the experiment and stem cells.
Although stem cells may have the capacity for "immortal" renewal, the alteration of stem cell status and
genetic material by in vitro culture can seriously affect the outcome of stem .
Therefore, proper characterization and expansion of stem cells is a critical step in ensuring the
development of your
> for stroke.
Ace Therapeutics has optimized the optimal culture conditions for different sources of stem cells and has established stable and standardized culture processes to ensure the scientific and reproducible generation and expansion of stem cells from different sources. Our aim is to ensure the yield and quality of your stem cell expansion. In addition, we also have an extensive and secure stem cell bank that can provide you with the stem cells you want.
For the development of stem cell therapies for stroke, an appropriate targeted intracerebral transplant route is critical. Traditional intracerebral injection routes or intracerebral transplantation of stem cells can lead to brain damage, there is a need to develop more appropriate intracerebral transplantation routes for the treatment of stroke. Ace Therapeutics has successfully established various stem cell transplant routes for the development of stem cell therapies for stroke, including but not limited to the intravenous route, intra-arterial route, intranasal route, intrathecal or intracerebroventricular route, and intracerebral route. We will select the appropriate transplant route for you based on your protocol and design.
After determining the cell type and transplantation route, we explore the effect of stem cells on stroke.
We offer custom stem development services for the treatment of stroke based on your experimental needs.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.